Jun Matsuda
Overview
Explore the profile of Jun Matsuda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
664
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shimada N, Matsuda J, Asano-Matsuda K, Tokuchi M, Aoudjit L, Masztalerz A, et al.
J Am Soc Nephrol
. 2025 Feb;
PMID: 40019803
No abstract available.
2.
Ajiki T, Ozono T, Sera F, Yonishi H, Matsuda J, Aguirre C, et al.
Amyloid
. 2025 Feb;
:1-8.
PMID: 39988769
Background: Hereditary transthyretin amyloidosis (ATTRv) is a fatal disease that affects multiple organs. Up to 30% of patients with ATTRv also experience renal complications, including proteinuria and a decline in...
3.
Kaimori J, Matsuda J, Jan A, Kawano Y, Kawaoka T, Asahina Y, et al.
Intern Med
. 2025 Jan;
PMID: 39814389
We encountered a family with hereditary renal failure, renal medullary cysts, pancreatic hypoplasia, hypomagnesemia, liver enzyme abnormalities, and diabetes mellitus (DM). We identified a novel heterozygous variant of HNF1B (NM_000458.4:c.791dup,...
4.
Nakamura J, Yamamoto T, Takabatake Y, Namba-Hamano T, Takahashi A, Matsuda J, et al.
JCI Insight
. 2024 Dec;
10(3).
PMID: 39699959
With the aging of society, the incidence of chronic kidney disease (CKD), a common cause of death, has been increasing. Transcription factor EB (TFEB), the master transcriptional regulator of the...
5.
Matsui S, Yamamoto T, Takabatake Y, Takahashi A, Namba-Hamano T, Matsuda J, et al.
Autophagy
. 2024 Oct;
21(3):583-597.
PMID: 39385699
The renoprotective effects of SLC5A2/SGLT2 (solute carrier 5 (sodium/glucose cotransporter), member 2) inhibitors have recently been demonstrated in non-diabetic chronic kidney disease (CKD), even without overt albuminuria. However, the mechanism...
6.
Suzuki T, Matsuda J, Tsukahara Y, Ohya A, Yamada A, Kurozumi M, et al.
Jpn J Radiol
. 2024 Sep;
43(2):301-308.
PMID: 39340741
Purpose: To evaluate the behavior of n-butyl cyanoacrylate-Lipiodol-iopamidol at a ratio of 2:3:1 (NLI231) with and without microcoils and/or flow control in embolization of medium-sized arteries in an in vitro...
7.
Tsukahara Y, Kurozumi M, Matsuda J, Nonaka T, Suzuki T, Fukamatsu F, et al.
Radiol Case Rep
. 2024 Aug;
19(10):4260-4265.
PMID: 39135676
Primary racemose hemangioma of the bronchial artery (RHBA) is a rare congenital condition characterized by enlarged and convoluted bronchial arteries, often forming fistulas between the pulmonary artery or vein. Herein,...
8.
Maeda S, Sakai S, Takabatake Y, Yamamoto T, Minami S, Nakamura J, et al.
J Am Soc Nephrol
. 2024 May;
PMID: 38819935
No abstract available.
9.
Nakayama Y, Fujiu K, Oshima T, Matsuda J, Sugita J, Matsubara T, et al.
Sci Immunol
. 2024 May;
9(95):eade3814.
PMID: 38787963
Patients with heart failure (HF) often experience repeated acute decompensation and develop comorbidities such as chronic kidney disease and frailty syndrome. Although this suggests pathological interaction among comorbidities, the mechanisms...
10.
Oida M, Hasumi E, Kohsaku G, Kunihiro K, Oshima T, Matsubara T, et al.
Sci Rep
. 2023 Oct;
13(1):16514.
PMID: 37783787
Clinical predictors for pacemaker-induced cardiomyopathy (PICM) (e.g., a wide QRS duration and left bundle branch block at baseline) have been reported. However, factors involved in the development of PICM in...